查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1530410

女性不孕症診斷市場規模、佔有率、趨勢分析報告：按測試、地區、細分預測，2024-2030

Female Infertility Diagnosis Market Size, Share & Trends Analysis Report By Test (Ovarian Reserve Testing, Hormone Testing, Hysterosalpingography, Other Tests), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

女性不孕症診斷市場趨勢

2023年，全球女性不孕症診斷市場規模估計為44.5億美元，預計2024年至2030年複合年成長率為8.6%。這個市場的成長是由生活方式的改變所推動的，生活方式的改變導致不孕症的增加和卵巢症候群（PCOS）等疾病的流行。根據世界衛生組織 (WHO) 2023 年 6 月發布的報告，PCOS 影響著約 8-13% 的育齡女性，而全球範圍內，多達 70% 的受影響者尚未得到診斷。

例如，根據 2022 年 6 月《韓國醫學雜誌》發表的一項研究，韓國在過去 30 年來的出生率是 OECD 國家中最低的。鑑於這一趨勢，韓國政府認知到促進健康懷孕和生育的重要性，並正在採取措施應對少子化，並推出了“第四個應對少子老齡化社會基本計劃”等舉措2021年。在支持高齡產婦懷孕的政策。因此，出生率下降預計將增加對不孕症診斷和輔助生殖技術的需求，從而擴大市場成長。

生活方式習慣對男性和女性的不孕症都有重大影響。吸菸、過量飲酒、不良飲食習慣和久坐的生活方式等因素會對生殖功能產生負面影響。此外，這些生活習慣可以透過多種機制影響生育能力，包括荷爾蒙失衡、氧化壓力、發炎和生殖功能下降。根據世界衛生組織的數據，低收入和中等收入國家的不孕症盛行率為16.5%，高所得國家為17.8%。

全球女性不孕症診斷市場細分報告

該報告預測了2018年至2030年國家層級的收益成長，並對每個子區隔的最新行業趨勢和商機進行了分析。在這項研究中，Grand View Research 根據測試和地區對女性不孕症診斷市場報告進行了細分：

  • 檢查展望（銷售，2018-2030）。
  • 卵巢儲備測試。
  • 造影。
  • 激素測試。
  • 其他測試。
  • 區域展望（收入，2018-2030）。
  • 北美。

美國。

加拿大

墨西哥

  • 歐洲

英國

德國

法國

義大利

西班牙

丹麥

瑞典

挪威

  • 亞太地區

日本

中國

印度

澳洲

韓國

泰國

  • 拉丁美洲

巴西

阿根廷

  • 中東和非洲

南非

沙烏地阿拉伯

阿拉伯聯合大公國

科威特

目錄

第1章調查方法和範圍

第 2 章執行摘要

第3章女性不孕症診斷市場的變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 女性不孕症診斷市場分析工具
    • 波特五力分析
    • PESTEL分析

第4章女性不孕症診斷市場：測試估算與趨勢分析

  • 細分儀表板
  • 女性不孕診斷市場：檢測波動分析
  • 女性不孕症診斷市場：通過測試展望
  • 卵巢儲備測試
  • 造影
  • 荷爾蒙測試
  • 其他測試

第5章 女性不孕診斷市場：區域估算及趨勢分析

  • 區域儀表板
  • 按地區分類的女性不孕症診斷市場：重點
  • 北美洲
    • 2018-2030年北美女性不孕症診斷市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
    • 歐洲
    • 2018-2030年歐洲女性不孕症診斷市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 2018-2030年亞太地區女性不孕症診斷市場估計與預測
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 2018-2030 年拉丁美洲女性不孕症診斷市場估計與預測
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030年中東和非洲女性不孕症診斷市場估計與預測
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭狀況

  • 市場參與企業分類
  • 公司市場分析
  • 主要企業簡介
    • PFCLA
    • Mayo Foundation for Medical Education and Research（MFMER）
    • Cleveland Clinic
    • Apricity Fertility UK Limited
    • King's Fertility Limited
    • Dallas IVF
    • Midwest Fertility Specialists
    • Europe IVF
    • Care Fertility
    • Aspire Fertility
Product Code: GVR-4-68040-369-6

Female Infertility Diagnosis Market Trends

The global female infertility diagnosis market size was estimated at USD 4.45 billion in 2023 and is projected to grow at a CAGR of 8.6% from 2024 to 2030. The market's growth is driven by the growing changes in lifestyle, which contribute to the rise in infertility and the prevalence of conditions such as polycystic ovary syndrome (PCOS). According to a World Health Organization (WHO) report published in June 2023, PCOS affects approximately 8-13% of women of reproductive age, with up to 70% of those affected going undiagnosed globally.

Additionally, a constant increase in the incidence of infertility in both sexes is projected to drive the market.For instance, according to a study published in Journal of Korean Medical Science, in June 2022, South Korea has experienced the most significant decline in fertility rates among all OECD countries in the last three decades. The Korean government has acknowledged the importance of promoting healthy pregnancies and childbirth considering this trend and has introduced policies aimed at addressing the low fertility rate and supporting advanced maternal age pregnancies through initiatives such as 'The Fourth Basic Plan on Low Fertility and Aging Society' launched in 2021. Consequently, the low fertility rate is expected to drive up the demand for infertility diagnosis and assisted reproductive technologies, leading to an expansion in the market growth.

The lifestyle habits play a significant role in influencing fertility in both men and women. Factors such as smoking, excessive alcohol consumption, poor diet, and sedentary habits can have detrimental effects on reproductive health. In addition, these lifestyle habits can impact fertility through various mechanisms, including hormonal imbalances, oxidative stress, inflammation, and impaired reproductive function. According to WHO, prevalence of infertility is 16.5% in low & middle income countries and 17.8% in high income countries.

Global Female Infertility Diagnosis Market Report Segmentation

This report forecasts revenue growth at country levels and provides an analysis on the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the female infertility diagnosis market report based on test and region:

  • Test Outlook (Revenue, USD Million, 2018 - 2030)
  • Ovarian Reserve Testing
  • Hysterosalpingography
  • Hormone testing
  • Other Tests
  • Region Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

UK

Germany

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

Japan

China

India

Australia

South Korea

Thailand

  • Latin America

Brazil

Argentina

  • Middle East & Africa

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Segment Definitions
      • 1.1.1.1. Tests
      • 1.1.1.2. Regional scope
    • 1.1.2. Estimates and forecasts timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.1.3. Purchased database
    • 1.1.4. GVR's internal database
    • 1.1.5. Secondary sources
    • 1.1.6. Primary research
    • 1.1.7. Details of primary research
  • 1.4. Information or Data Analysis
    • 1.1.8. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.1.9. Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Female Infertility Diagnosis Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Female Infertility Diagnosis Market Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis

Chapter 4. Female Infertility Diagnosis Market: Tests Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Female Infertility Diagnosis Market: Tests Movement Analysis
  • 4.3. Female Infertility Diagnosis Market by Tests Outlook (USD Million)
  • 4.4. Ovarian Reserve Testing
    • 4.4.1. Ovarian Reserve Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Hysterosalpingography
    • 4.5.1. Hysterosalpingography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Hormone Testing
    • 4.6.1. Hormone Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.7. Other Tests
    • 4.7.1. Other Tests Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Female Infertility Diagnosis Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Dashboard
  • 5.2. Regional Female Infertility Diagnosis Market: Key Takeaways
  • 5.3. North America
    • 5.3.1. North America Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Key Country Dynamics
      • 5.3.2.2. Competitive Scenario
      • 5.3.2.3. Regulatory Framework
      • 5.3.2.4. Reimbursement scenario
      • 5.3.2.5. U.S. Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Key Country Dynamics
      • 5.3.3.2. Competitive Scenario
      • 5.3.3.3. Regulatory Framework
      • 5.3.3.4. Reimbursement scenario
      • 5.3.3.5. Canada Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Mexico
      • 5.3.4.1. Key Country Dynamics
      • 5.3.4.2. Competitive Scenario
      • 5.3.4.3. Regulatory Framework
      • 5.3.4.4. Reimbursement scenario
      • 5.3.4.5. Mexico Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Europe
    • 5.3.6. Europe Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. UK
      • 5.3.7.1. Key Country Dynamics
      • 5.3.7.2. Competitive Scenario
      • 5.3.7.3. Regulatory Framework
      • 5.3.7.4. Reimbursement scenario
      • 5.3.7.5. UK Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.8. Germany
      • 5.3.8.1. Key Country Dynamics
      • 5.3.8.2. Competitive Scenario
      • 5.3.8.3. Regulatory Framework
      • 5.3.8.4. Reimbursement scenario
      • 5.3.8.5. Germany Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.9. France
      • 5.3.9.1. Key Country Dynamics
      • 5.3.9.2. Competitive Scenario
      • 5.3.9.3. Regulatory Framework
      • 5.3.9.4. Reimbursement scenario
      • 5.3.9.5. France Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.10. Italy
      • 5.3.10.1. Key Country Dynamics
      • 5.3.10.2. Competitive Scenario
      • 5.3.10.3. Regulatory Framework
      • 5.3.10.4. Reimbursement scenario
      • 5.3.10.5. Italy Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.11. Spain
      • 5.3.11.1. Key Country Dynamics
      • 5.3.11.2. Competitive Scenario
      • 5.3.11.3. Regulatory Framework
      • 5.3.11.4. Reimbursement scenario
      • 5.3.11.5. Spain Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.12. Denmark
      • 5.3.12.1. Key Country Dynamics
      • 5.3.12.2. Competitive Scenario
      • 5.3.12.3. Regulatory Framework
      • 5.3.12.4. Reimbursement scenario
      • 5.3.12.5. Denmark Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.13. Sweden
      • 5.3.13.1. Key Country Dynamics
      • 5.3.13.2. Competitive Scenario
      • 5.3.13.3. Regulatory Framework
      • 5.3.13.4. Reimbursement scenario
      • 5.3.13.5. Sweden Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.14. Norway
      • 5.3.14.1. Key Country Dynamics
      • 5.3.14.2. Competitive Scenario
      • 5.3.14.3. Regulatory Framework
      • 5.3.14.4. Reimbursement scenario
      • 5.3.14.5. Norway Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Asia Pacific
    • 5.4.1. Asia Pacific Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.2. Japan
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Competitive Scenario
      • 5.4.2.3. Regulatory Framework
      • 5.4.2.4. Reimbursement scenario
      • 5.4.2.5. Japan Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. China
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Competitive Scenario
      • 5.4.3.3. Regulatory Framework
      • 5.4.3.4. Reimbursement scenario
      • 5.4.3.5. China Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. India
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Competitive Scenario
      • 5.4.4.3. Regulatory Framework
      • 5.4.4.4. Reimbursement scenario
      • 5.4.4.5. India Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.5. South Korea
      • 5.4.5.1. Key Country Dynamics
      • 5.4.5.2. Competitive Scenario
      • 5.4.5.3. Regulatory Framework
      • 5.4.5.4. Reimbursement scenario
      • 5.4.5.5. South Korea Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.6. Australia
      • 5.4.6.1. Key Country Dynamics
      • 5.4.6.2. Competitive Scenario
      • 5.4.6.3. Regulatory Framework
      • 5.4.6.4. Reimbursement scenario
      • 5.4.6.5. Australia Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.4.7. Thailand
      • 5.4.7.1. Key Country Dynamics
      • 5.4.7.2. Competitive Scenario
      • 5.4.7.3. Regulatory Framework
      • 5.4.7.4. Reimbursement scenario
      • 5.4.7.5. Thailand Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Latin America
    • 5.5.1. Latin America Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.2. Brazil
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Competitive Scenario
      • 5.5.2.3. Regulatory Framework
      • 5.5.2.4. Reimbursement scenario
      • 5.5.2.5. Brazil Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Argentina
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Competitive Scenario
      • 5.5.3.3. Regulatory Framework
      • 5.5.3.4. Reimbursement scenario
      • 5.5.3.5. Argentina Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Middle East & Africa
    • 5.6.1. Middle East & Africa Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.2. South Africa
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Competitive Scenario
      • 5.6.2.3. Regulatory Framework
      • 5.6.2.4. Reimbursement scenario
      • 5.6.2.5. South Africa Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. Saudi Arabia
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Competitive Scenario
      • 5.6.3.3. Regulatory Framework
      • 5.6.3.4. Reimbursement scenario
      • 5.6.3.5. Saudi Arabia Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. UAE
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Competitive Scenario
      • 5.6.4.3. Regulatory Framework
      • 5.6.4.4. Reimbursement scenario
      • 5.6.4.5. UAE Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. Kuwait
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Competitive Scenario
      • 5.6.5.3. Regulatory Framework
      • 5.6.5.4. Reimbursement scenario
      • 5.6.5.5. Kuwait Female Infertility Diagnosis Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Company Market Position Analysis
  • 6.3. Key Company Profiles
    • 6.3.1. PFCLA
      • 6.3.1.1. Company overview
      • 6.3.1.2. Financial performance
      • 6.3.1.3. Service benchmarking
      • 6.3.1.4. Strategic initiatives
    • 6.3.2. Mayo Foundation for Medical Education and Research (MFMER)
      • 6.3.2.1. Company overview
      • 6.3.2.2. Financial performance
      • 6.3.2.3. Service benchmarking
      • 6.3.2.4. Strategic initiatives
    • 6.3.3. Cleveland Clinic
      • 6.3.3.1. Company overview
      • 6.3.3.2. Financial performance
      • 6.3.3.3. Service benchmarking
      • 6.3.3.4. Strategic initiatives
    • 6.3.4. Apricity Fertility UK Limited
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Service benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. King's Fertility Limited
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Service benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Dallas IVF
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Service benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. Midwest Fertility Specialists
      • 6.3.7.1. Company overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Service benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Europe IVF
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Service benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. Care Fertility
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Service benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. Aspire Fertility
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Service benchmarking
      • 6.3.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 4 North America Female Infertility Diagnosis market, by region, 2018 - 2030 (USD Million)
  • Table 5 North America Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 6 U.S. Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 7 Canada Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 8 Mexico Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 9 Europe Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 10 Europe Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 11 UK Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 12 Germany Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 13 France Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 14 Italy Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 15 Spain Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 16 Norway Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 17 Sweden Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 18 Denmark Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 19 Asia Pacific Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 20 Asia Pacific Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 21 Japan Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 22 China Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 23 India Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 24 Australia Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 25 South Korea Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 26 Thailand Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 27 Latin America Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 28 Latin America Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 29 Brazil Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 30 Argentina Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 31 Middle East & Africa Female Infertility Diagnosis market, by country, 2018 - 2030 (USD Million)
  • Table 32 Middle East & Africa Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 33 South Africa Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 34 Saudi Arabia Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 35 UAE Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)
  • Table 36 Kuwait Female Infertility Diagnosis market, by tests, 2018 - 2030 (USD Million)

List of Figures

  • Fig 1. Information Procurement
  • Fig 2. Primary Research Pattern
  • Fig 3. Market Research Approaches
  • Fig 4. Value Chain-Based Sizing & Forecasting
  • Fig 5. Market Formulation & Validation
  • Fig 6. Female infertility diagnosis market segmentation
  • Fig 7. Market driver analysis (Current & future impact)
  • Fig 8. Market restraint analysis (Current & future impact)
  • Fig 9. Porter's Five Forces Analysis
  • Fig 10. PESTEL Analysis
  • Fig 11. Female infertility diagnosis market: Tests segment dashboard
  • Fig 12. Female infertility diagnosis market: Tests movement analysis, 2023 & 2030
  • Fig 13. Ovarian reserve testing products market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 14. Hysterosalpingography market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 15. Hormone testing market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 16. Other tests market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 17. Female infertility diagnosis market: Regional key takeaways (USD Million)
  • Fig 18. Female infertility diagnosis market regional outlook, 2023 & 2030, (USD Million)
  • Fig 19. North America female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 20. U.S. female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 21. Canada female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 22. Mexico female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 23. Europe female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 24. UK female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 25. Germany female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 26. France female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 27. Spain female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 28. Italy female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 29. Sweden female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 30. Norway female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 31. Denmark female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 32. Asia Pacific female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 33. China female infertility diagnosis estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 34. Japan female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 35. India female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 36. South Korea female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 37. Australia female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 38. Thailand female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 39. Latin America female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 40. Brazil female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 41. Argentina female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 42. Middle East and Africa female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 43. South Africa female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 44. Saudi Arabia female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 45. UAE female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig 46. Kuwait female infertility diagnosis market estimates and forecasts, 2018 - 2030 (USD Million)